Japan researchers close in on stem cell trial
Researchers in Japan have moved one step closer to clinical trials using adult stem cells in a therapy they hope will prove a cure for common sight problems, an official said Thursday.
Stem cell research in the UK reaches significant milestone
Stem cell scientists at King's College London will today announce they have submitted to the UK Stem Cell Bank (UKSCB) their first clinical grade human embryonic stem (hES) cell lines that are free from animal-derived products, ...
FDA panel unanimously backs Regeneron eye drug
(AP) -- A panel of federal health experts voted unanimously in favor of a new eye drug from Regeneron, bringing the company one step closer to competing against a blockbuster Roche drug that currently dominates the market.
First patients enroll in US stem cell trials on blindness
The first clinical trials that examine the use of stem cells to treat two forms of blindness are ready to begin now that patients have been enrolled, a US company announced on Thursday.
Stem cell therapy for age-related macular degeneration -- a step closer to reality
The notion of transplanting adult stem cells to treat or even cure age-related macular degeneration has taken a significant step toward becoming a reality. In a study published today in Stem Cells, Georgetown University Medica ...
Omega-3 fatty acid intake linked with reduced risk of age-related macular degeneration in women
Regular consumption of fish and omega-3 fatty acids found in fish is associated with a significantly reduced risk of developing age-related macular degeneration in women, according to a report posted online today that will ...
Advanced macular degeneration is associated with an increased risk
Older people with late-stage, age-related macular degeneration (AMD) appear to be at increased risk of brain hemorrhage (bleeding stroke), but not stroke caused by brain infarction (blood clot), according to research presented ...
Pivotal discoveries in age-related macular degeneration
A team of researchers, led by University of Kentucky ophthalmologist Dr. Jayakrishna Ambati, has discovered a molecular mechanism implicated in geographic atrophy, the major cause of untreatable blindness ...
Rush for patents is choking US stem cell research
Cures for paralysis, blindness and diabetes could all be in reach with embryonic stem cell research, but the pursuit of medical progress is being choked by the US rush to secure patents, experts say.
Study evaluates prevalence of age-related macular degeneration in the United States
An estimated 6.5 percent of Americans age 40 and older have the eye disease age-related macular degeneration, a lower rate than was reported 15 years ago, according to a report in the January issue of Archives of Ophthalmology.
Seafood diet may keep vision loss at bay
Dishing up fish and shellfish more often at meals could help some older adults protect their eyesight longer.
Team finds mutation involved in macular degeneration
Researchers from the Wellcome Trust Centre for Cell-Matrix Research in Manchester have revealed more about how a particular genetic change significantly raises the risk of developing age-related macular degeneration.
Certain new therapies for age-related eye disease do not appear to increase heart risks
Newer treatments for age-related macular degeneration (AMD)including an intravitreous (into the eye) injection of a chemotherapy drug and use of a related compound approved for use against the eye diseasedo not ...
Researchers find no difference in drugs for macular degeneration
Researchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) ...